Canada markets close in 3 hours 55 minutes

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.40-0.02 (-0.18%)
As of 12:04PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 810.37M
Enterprise Value 370.60M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.85
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.47

Trading Information

Stock Price History

Beta (5Y Monthly) 1.73
52-Week Change 3-46.13%
S&P500 52-Week Change 324.19%
52 Week High 331.46
52 Week Low 39.56
50-Day Moving Average 313.99
200-Day Moving Average 317.10

Share Statistics

Avg Vol (3 month) 3829.54k
Avg Vol (10 day) 3664.05k
Shares Outstanding 570.96M
Implied Shares Outstanding 670.96M
Float 850.35M
% Held by Insiders 14.27%
% Held by Institutions 1115.08%
Shares Short (Apr 15, 2024) 416.64M
Short Ratio (Apr 15, 2024) 422.49
Short % of Float (Apr 15, 2024) 431.89%
Short % of Shares Outstanding (Apr 15, 2024) 423.45%
Shares Short (prior month Mar 15, 2024) 416.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.53%
Return on Equity (ttm)-67.09%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -247.6M
Net Income Avi to Common (ttm)-292.19M
Diluted EPS (ttm)-4.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)482.92M
Total Cash Per Share (mrq)6.8
Total Debt (mrq)45.77M
Total Debt/Equity (mrq)10.46%
Current Ratio (mrq)7.16
Book Value Per Share (mrq)6.18

Cash Flow Statement

Operating Cash Flow (ttm)-207.82M
Levered Free Cash Flow (ttm)-86.97M